Lars Holtug
Director · 1 filing · Latest: Sep 2, 2026
Ascendis Pharma A/S
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
ASND | Lars Holtug | Director | Sep 2, 2026 | Sale | $264.13 | 236 | $62.3K | 4,000 | |
ASND | HOLTUG LARS | — | Sep 2, 2026 | Proposed Sale | $264.13 | 236 | $62.3K | — | |
ASND | HOLTUG LARS | — | Mar 2, 2026 | Proposed Sale | $242.09 | 2,100 | $508.4K | — | |
ASND | HOLTUG LARS | — | Mar 4, 2025 | Proposed Sale | $152.12 | 1,470 | $223.6K | — |